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Abstract The purinergic P2X7 receptor is an ATP-receptor
channel predominantly expressed in immune cells. P2X7 has been
cloned from human, rat and mouse. Here we report cloning of the
Xenopus laevis P2X7 receptor (xP2X7). xP2X7 is only about
50% identical to the mammalian homologues, shows a broad
tissue expression pattern, and has the electrophysiological
characteristics typical of a P2X7 receptor: low agonist affinity
(EC50 about 2.6 mM) and a non-desensitizing current. More-
over, expression of xP2X7 in Xenopus oocytes is sufficient to
induce the formation of a large pore, which is permeable to
large cations such as NMDG+. Identification of a non-
mammalian P2X7 receptor may help to identify functionally
important parts of the protein. ß 2002 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
P2X receptors are ion channels gated by extracellular ATP.
So far, seven di¡erent P2X subunits have been cloned
(P2X1ÿ7), which form a gene family [1]. They have two trans-
membrane domains with intracellular termini and a rather
large extracellular loop [2,3] and form non-selective cation
channels with a high permeability to Ca2. Various P2X re-
ceptors show di¡erences both in the a⁄nity to ATP and in the
kinetics of activation and inactivation. P2X1 and P2X3 show
high agonist a⁄nity (EC50, V1 WM) and rapid activation and
desensitization, whereas P2X2, and P2X4ÿ6 have a low agonist
a⁄nity (EC50,V10 WM), are slowly activating, and show only
partial desensitization. P2X7 shows the lowest agonist a⁄nity
(EC50, 100^1000 WM), slow activation, and almost no desensi-
tization [4^6]. Moreover, it is believed that the free ATP ion,
ATP43, is the e¡ective agonist at P2X7, since solutions lacking
Mg2 and Ca2 give greater agonist potency. And, ATP is
only a partial agonist, since the ATP analogue 3P-O-(4-benzo-
yl)-benzoyl-ATP (BzATP) has an approximately 10-fold lower
EC50 [4^6].
These properties of the P2X7 receptor match the properties
of the P2Z receptor, which had been characterized on immune
cells, especially macrophages [7^11]. Another characteristic
feature of the P2Z receptor is the fact that prolonged activa-
tion or repeated activation of the channel leads to the appear-
ance of a large, unselective pore, which is permeable to or-
ganic cations of a size up to 900 Da. Expression of the P2X7
receptor in various heterologous expression systems reconsti-
tutes this property leading to the formation of a large pore
and eventually to cell lysis [4^6]. There are, though, con£icting
reports on the formation of the large pore in Xenopus oocytes,
a commonly used expression system. It has been reported that
expression of the rat P2X7 receptor leads to formation of the
large pore [12] as well as that neither expression of the rat nor
of the human P2X7 receptor are su⁄cient for formation of the
large pore in Xenopus oocytes [13,14]. This has been taken as
evidence that factors other than the P2X7 receptor are neces-
sary for ATP-induced permeabilization. Since the P2Z recep-
tor has cytolytic properties in macrophages and since this
property may have important functions in the immune system,
understanding of the mechanism that governs formation of
the large pore is a prerequisite for a deeper understanding
of the function of the P2X7/P2Z receptor in the immune sys-
tem.
Here we report cloning of the Xenopus P2X7 receptor. Ex-
pression of this new orthologue leads to formation of a typical
P2X7 phenotype characterized by low agonist a⁄nity and in-
complete desensitization. Moreover, prolonged agonist appli-
cation leads to the formation of a large pore permeable to
cations such as N-methyl-D-glucamine (NMDG) (195 Da) in
Xenopus oocytes. Cloning of the amphibian P2X7 receptor
may facilitate our understanding of the large pore formation
and identi¢cation of functionally important parts of the pro-
tein.
2. Materials and methods
2.1. Cloning of xP2X7
An expressed sequence tag (EST) from Xenopus laevis (accession
number: BE509086; IMAGE clone ID: 3397314; provided by the
Resource Center/Primary Database, Berlin, Germany) showing ho-
mology to P2X7 receptors was entirely sequenced. It contained the
3P-end of the coding sequence and a long (2203 bp) 3P-untranslated
region (3P-UTR). This sequence was used to design primers for rapid
ampli¢cation of 5P-complementary DNA (cDNA) ends (5P-RACE),
xP2X7-5PRACE 5P-CCAATCGTCGGAAACCGTAATGAGG-3P
and, for the nested PCR reaction, xP2X7-5PNRACE 5P-CAGTCC-
CAGTTGATCTCAATGCCC-3P. Using the SMART RACE cDNA
ampli¢cation kit (Clontech, Palo Alto, CA, USA), 5P-RACE was per-
formed with polyA RNA from stomach of an adult X. laevis female.
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PCR products were subcloned using the TOPO-TA cloning kit (Invi-
trogen, Groningen, The Netherlands) and sequenced. One clone of
about 1300 bp contained the entire 5P-coding region and 530 bp of
5P-UTR. The 5P-UTR contained an in-frame stop codon upstream of
the methionine.
For expression studies, the entire coding sequence of xP2X7 was
ampli¢ed from Xenopus stomach cDNA by PCR using Expand
High Fidelity (Roche, Mannheim, Germany). PCR primers were
xP2X7-5P 5P-CCGGAGCTCGCCCTGCAGAAATGACACTGACC-
3P and xP2X7-3P 5P-CGGGGTACCTTATGGGCCTTCTGTTTG-
CAGG-3P. Using terminal restriction endonuclease recognition se-
quences (SacI and KpnI), the PCR product was ligated in the oocyte
expression vector pRSSP containing the 5P-UTR from Xenopus L
globin and a poly(A) tail. Several clones from two independent
PCR reactions were sequenced to exclude PCR errors.
The full-length sequence of xP2X7 (accession number: AJ345114)
was assembled from the 5P-UTR of the RACE product, the coding
sequence of the expression construct and the 3P-UTR from EST clone
BE509086.
A second EST obtained from X. laevis cDNA (accession number:
BG814668; IMAGE clone ID: 4173287; provided by the RC/PD) was
sequenced. This clone contained the entire coding region of xP2X7,
which was interrupted by an intron of 234 bp. The sequence of this
EST showed the following amino acid exchanges compared to xP2X7
cloned by PCR: F41Y, N105K, A224T, I238M, T267K, Q314K,
Y364N, H376N, and E472Q. There were six additional nucleotide
di¡erences not changing the amino acid.
2.2. Semiquantitative RT-PCR
Total RNA was isolated from Xenopus tissues with peqGOLD
RNApure (peqLab). It was digested with DNase, integrity of RNA
checked on an agarose gel and 2 Wg reverse transcribed using oligo-dT
and SuperScript (Life Technologies, Karlsruhe, Germany). 1/13 of the
reaction was ampli¢ed for 30 cycles (94‡C for 30 s, 66‡C for 30 s,
72‡C for 5 s). PCR primers were xP2X7-RT-u 5P-TATGCTGCCTC-
CTGCCTGG-3P and xP2X7-RT-l 5P-CAGCAGTTGGGGATCACT-
GC-3P. Ampli¢cation products were transferred to nylon membrane
and then probed with a 32P-labeled 500-bp BglII cDNA fragment
from xP2X7. Primers for control ampli¢cation of GAPDH were
xGAPDH-RT-u 5P-TCACAACCACAGAGAAGGCC-3P and xGAP-
DH-RT-l 5P-CCATCTCTCCACAGCTTGCC-3P. Ampli¢cation was
for 30 cycles (94‡C for 30 s, 60‡C for 30 s, 72‡C for 10 s).
2.3. Electrophysiology
Oocytes, which had been surgically removed from female X. laevis,
were injected with 30^100 pg of cRNA encoding xP2X7. They were
incubated at 19‡C in OR-2 solution containing (in mM) NaCl 82.5,
KCl 2.5, Na2HPO4 1.0, HEPES 5.0, polyvinylpyrrolidon 0.5 g/l,
MgCl2 1.0, CaCl2 1.0 (pH 7.3). On the following day, the oocytes
were treated with collagenase type II (0.33 g/l; Sigma-Aldrich, Dei-
senhofen, Germany) for 40 min in order to facilitate the removal of
the follicular membrane, which was done a further day later.
Measurements were done at room temperature 3^7 days after in-
jection using two-electrode voltage-clamp. Currents were recorded
and ¢ltered at 100 Hz with a TurboTec 03X ampli¢er (npi electronic
GmbH, Tamm, Germany), digitized at 1 kHz using the AD/DA inter-
face PCI 1200 (National Instruments, Austin, TX, USA) and stored
on hard disk. Complete solution exchange at whole oocytes could be
obtained within less than 1 s [15] using the oocyte testing carousel
controlled by the interface OTC-20 (npi electronic GmbH). Data ac-
quisition and solution exchange were managed using the software
CellWorks 5.1.1 (npi electronic GmbH). The bath solution had the
following composition (in mM): NaCl or NMDGCl 98.0, HEPES 5.0,
ni£umic acid 0.1 (pH 7.45). Ni£umic acid was used to block the large
conductance induced in oocytes by divalent-free extracellular solu-
tions [16]. Divalent-free extracellular solutions were used in order to
permit formation of a large unselective pore by P2X7 receptors. ATP,
N,N-hexamethylene amiloride (HMA), BzATP, collagenase, 1-[N,O-
bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine
(KN-62) and ni£umic acid were all purchased from Sigma-Aldrich,
Deisenhofen, Germany.
2.4. Data analysis
Current amplitudes for concentration^response curves were esti-
mated using the calculated maximum value of a ¢t to the exponential
rise phase of the current trace (Igor PRO, WaveMetrics, Lake Oswe-
go, OR, USA). In order to minimize induction of large pore forma-
tion in experiments for concentration^response curves a two-pulse
protocol was used: the ¢rst current pulse (4 s) was induced by the
reference concentration of agonist (1 mM ATP/100 WM BzATP), the
second one was induced by the testing concentration of agonist. Cur-
rent amplitudes induced by testing concentrations were then normal-
ized to the amplitudes induced by the reference concentration. The
two-pulse protocol was also carried out with the reference concentra-
tion as testing concentration to estimate reproducibility of channel
activation. The resulting concentration^response curves were ¢tted
using the logistic function: A+(B3A)/[1+(EC50/C)D], where A is the
minimum response, B is the maximum response, C is the concentra-
tion, EC50 is the concentration at which half-maximal response is
obtained, and D is the Hill coe⁄cient. For better comparison of con-
centration^response curves with ATP and BzATP, values were then
normalized to the maximum response B obtained from the respective
¢t.
Voltage ramps, which were used to determine reversal potentials,
were run from 3120 mV to +20 mV within 1 s. Current traces were
leak-subtracted (Igor Pro). The shift in reversal potential in experi-
ments using extracellular solution with NMDG compared to experi-
ments using extracellular solution with Na were used to calculate
relative permeabilities: PNMDG+/PNa+ = exp(NErevF/RT), where
PNMDG+ is the permeability to NMDG, PNa+ is the permeability
to Na and NErev is the shift in reversal potential. F, R and T have
their usual meanings. Results are reported as mean þ S.D. Statistical
analysis was done with Student’s t-test.
For YO-PRO-1 experiments, each oocyte was injected with 10 ng of
cRNA encoding xP2X7. YO-PRO-1 was purchased from Molecular
Probes (Eugene, OR, USA). Images were obtained using an Olympus
AX-70 light microscope (Olympus Optical Corp., Hamburg, Ger-
many) equipped with epi£uorescence and stored using a digital cam-
era and analySIS software (Soft Imaging System GmbH, Mu«nster,
Germany).
3. Results and discussion
3.1. Molecular cloning of X. laevis P2X7
An EST was used to clone full-length P2X7 from X. laevis
(see Section 2). The cDNA for xP2X7 codes for a protein of
553 amino acids (Fig. 1). It has all the hallmarks of P2X
receptors: two hydrophobic domains, conserved cysteines be-
tween the hydrophobic domains, and a short N-terminus. The
C-terminus of xP2X7 is long (about 215 amino acids), which is
a characteristic feature of P2X7 receptors [4]. Overall homol-
ogy to mammalian P2X7 receptors is rather low (about 50%
identity) as can be expected since species divergence between
mammals and amphibians occurred over 300 million years
ago. Sequence identity is signi¢cantly higher in the hydropho-
bic domains and in the putative extracellular loop between the
hydrophobic domains.
Assuming that N- and C-termini are intracellularly located,
xP2X7 has six potential N-glycosylation sites (Fig. 1). The last
four of these sites are conserved in rat, mouse and human
P2X7, whereas the ¢rst two are speci¢c for xP2X7. There
are two neighboring consensus sites for phosphorylation by
protein kinase C at the N-terminus and one at the C-terminus.
One of the sites at the N-terminus is completely conserved in
P2X receptors, whereas the other two sites are speci¢c for
xP2X7. There are 10 cysteine residues in the putative extracel-
lular loop of xP2X7, which are conserved in all P2X receptors.
At the cytoplasmic tail there are several conserved cysteine
repeats, which may serve as additional membrane anchors
via palmitoylation.
After cloning of xP2X7, another EST clone showing homol-
ogy to P2X7 receptors became available in the database. This
clone contains the entire coding region of xP2X7, which is
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interrupted at the position corresponding to amino acid 234
by an intron of 234 bp. This intron contains several stop
codons, which would lead to a premature end of the protein
before the second transmembrane domain. Therefore, this
clone most likely represents an immature transcript. When
we ampli¢ed the coding sequence of xP2X7, we found that a
signi¢cant proportion (s 70%) of PCR products contained
this intron. If a truncated P2X7 receptor has a regulatory
role remains to be investigated. Moreover, there are several
amino acid di¡erences between xP2X7 and the EST clone (see
Section 2). This may be due to strain variations or to poly-
ploidy of Xenopus.
3.2. Analysis of xP2X7 mRNA distribution
The expression of xP2X7 was studied on a panel of di¡erent
Xenopus tissues by RT-PCR. All 12 tissues tested were pos-
Fig. 1. Sequence alignment of xP2X7 with its mammalian homologues. Amino acids showing a high degree of identity are shown as white let-
ters on black background, those showing a high degree of homology as black letters on gray background. Transmembrane domains are indi-
cated by bars, conserved cysteines by closed circles, potential glycosylation sites by asterisks, potential sites for phosphorylation by protein ki-
nase C by arrowheads, and potential palmitoylation sites by wavy lines. Transmembrane domains have been predicted using the TMpred
program (http://www.ch.embnet.org/). Accession number for xP2X7 is AJ345114. Accession numbers for hP2X7, mP2X7, and rP2X7 are
Y09561, AJ009823, and X95882, respectively.
Fig. 2. RT-PCR analysis revealing broad tissue expression of xP2X7
mRNA. PCR for GAPDH shows comparable ampli¢cation in all
tissues examined. Control was without cDNA.
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itive for xP2X7 mRNA expression (Fig. 2). Abundance in
bladder was low, whereas it was slightly higher in spleen, liver,
skin, and stomach compared to other tissues. The P2X7 re-
ceptor shows such a broad tissue expression pattern also in
mammals [5]. mRNA expression in some of these tissues is
probably due to in¢ltration by immune cells, but P2X7 has
recently also been detected in a variety of non-immune cells
[17]. Given the high expression level of xP2X7 in spleen, it is
likely that immune cells express a P2X7/P2Z receptor also in
Xenopus. The immune system of amphibians shares all the
basic cell types with the immune system of mammals and it
is, therefore, likely that P2X7 serves the same functions in the
amphibian and in the mammalian immune system.
3.3. Functional expression of xP2X7 in Xenopus oocytes
Brief application of 1 mM ATP for 4 s to oocytes express-
ing xP2X7 receptors evoked an inward current, which con-
sisted of an exponentially and a linearly increasing component
(see Fig. 3A, upper right). Following washout of ATP, the
inward current deactivated with a fast and a slowly deactivat-
ing component as it has recently been described for the human
receptor [18]. But usually, after washout of ATP, a slowly
increasing conductance appeared (Fig. 3A, left). A further
4 s ATP pulse, after washout for 60 s, evoked again an inward
Fig. 3. Electrophysiological characteristics of xP2X7. A: Left, repre-
sentative current trace showing inward currents evoked by repetitive
applications of ATP. A slowly increasing inward current appeared
several seconds after washout of the agonist. Short ATP applica-
tions (1 mM for 4 s) were separated by washout for 60 s. Horizon-
tal bars indicate agonist application. Holding potential was 360
mV. Upper right, enlargement of a representative current trace
showing the kinetics of currents through xP2X7. In some cases the
current desensitized partially in the presence of agonist. Lower right,
activation of xP2X7 by the agonist BzATP elicited the same behav-
ior as activation by ATP. B: Pharmacology of xP2X7. Left, xP2X7
was activated by ATP (1 mM ATP), then ATP was washed out and
oocytes were incubated in KN-62 (3 WM) for 5 min followed by the
second ATP pulse in the presence of KN-62. KN-62 did not signi¢-
cantly in£uence current amplitude. Also, the slowly activating cur-
rent between ATP pulses was similar to control measurements
(n = 5; Ps 0.05). Middle, Mg2 ions at a concentration of 3 mM
blocked the fast activating as well as the slowly activating current
(representative current trace). Right, extracellular protons at pH 6.0
also blocked both current components completely (representative
current trace). C: Concentration^response curves for ATP (¢lled
circle) and BzATP (¢lled square). Number of individual measure-
ments for the corresponding testing concentration is indicated as n.
Symbols represent mean þ S.D. EC50 was 2.6 mM and 139 WM for
ATP and BzATP, respectively.
Fig. 4. Characterization of large pore formation by xP2X7 in Xeno-
pus oocytes. A: HMA (100 WM) blocked selectively and completely
the slowly activating current, which appeared after washout of ago-
nist (n = 4). The protocol used was as described for Fig. 3A. B:
Membrane potential was clamped to 360 mV and every 10 s a volt-
age ramp (1 s) from 3120 mV to +20 mV was run. Measurements
were done in extracellular solution containing NMDG. ATP (1
mM) was applied continuously for 5 min. During ATP application
a slowly increasing inward current appeared, which, upon washout,
deactivated rapidly but partially. The remaining inward current
showed a delayed deactivation. C: Current traces during voltage
ramps at the indicated times after onset of agonist application from
experiments shown in (B) are overlayed. The horizontal line indi-
cates the level of zero current. During activation of xP2X7 the re-
versal potential shifted signi¢cantly (P6 0.001) within 5 min, where-
as it did not shift in measurements using the same protocol but
with extracellular solution containing Na (inset) (n = 8, each). D:
Mean þ S.D. for reversal potentials (Erev) and relative permeabilities
(PNMDG+/PNa+). Increase of the relative permeability was around
seven-fold. ‘initial’ is the value 10 s after onset of ATP application.
E: Left, xP2X7 expressing oocyte incubated in 10 WM YO-PRO-1
and 300 WM BzATP for 5 min. Fluorescence indicates dye uptake
(not quanti¢ed). A similar picture was seen in six out of six experi-
ments. Right, as a control, non-injected oocytes were analyzed using
the same protocol. No dye uptake was seen in six out of six experi-
ments.
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current of comparable amplitude, which added to the slowly
increasing conductance. The slowly increasing conductance
increased faster with further ATP applications. Upon ¢nal
washout of the agonist, it deactivated within several minutes
(indicated as dashed line in Fig. 3A, left and lower right;
shown in Fig. 3B, left). In control measurements without ap-
plication of ATP, we did not observe this increase in back-
ground current (not shown), showing that it is due to activa-
tion of xP2X7. With BzATP as agonist, currents through
xP2X7 receptors showed the same behavior as currents acti-
vated by ATP (Fig. 3A, lower right). Apart from the slowly
increasing conductance following washout of the agonist, this
current behavior matches rather closely the behavior of hu-
man P2X7 receptor expressed in oocytes [14,18]. In contrast,
the rat subtype, when expressed in oocytes, undergoes a
strong current run-down following activation [13].
The isoquinoline KN-62, a CAMK-II blocker, is an antag-
onist at the human and mouse P2X7 receptor but has no e¡ect
on the rat subtype [19,6]. 1 WM of KN-62 is su⁄cient to
completely inhibit activation of human P2X7 receptors. Sim-
ilar to the rat receptor, xP2X7 was not inhibited by KN-62
(3 WM; Fig. 3B, left). A further property of xP2X7, which is
characteristic for P2X7 receptors, was its block by extracellu-
lar divalent cations. 3 mM Mg2 completely blocked the de-
activating current as well as the slowly increasing conductance
(Fig. 3B, middle trace). The approximate IC50 of 0.53 mM
(n = 4^6, not shown) was similar to that reported for rP2X7
(V0.47 mM; [20]). P2X7 receptors are also inhibited by extra-
cellular protons. At a pH, at which currents through the
rP2X7 receptor are half-maximally inhibited (V pH 6.1;
[20]), currents through the Xenopus subtype were already com-
pletely inhibited (Fig. 3B, right). Again, both the deactivating
as well as the slowly increasing current component were in-
hibited. Inhibition of xP2X7 was half-maximal at pH 7.7
(n = 4^7, not shown), meaning that xP2X7 is signi¢cantly in-
hibited by extracellular protons under physiological condi-
tions.
Determination of concentration^response curves with P2X7
receptors is problematic. Current amplitude, evoked by equal
agonist concentrations, was generally comparable but became
more variable the larger the slowly increasing current compo-
nent was. Therefore, we compared only two current ampli-
tudes on the same oocyte, one evoked by the reference con-
centration of the agonist and the other evoked by a testing
concentration of the agonist. EC50 was then calculated as
described in Section 2. Due to these technical problems,
EC50 values should be seen as estimates. Fig. 3C shows the
normalized concentration^response curves for ATP and its
analog BzATP: EC50 for ATP was approximately 2.6 mM
(n = 3^5) and 139 WM for BzATP (n = 2^5). Thus, xP2X7 is
the least ATP-sensitive member of the P2X receptor family.
Higher sensitivity to BzATP compared to ATP is a unique
feature of P2X7 receptors, clearly demonstrating that we in-
deed cloned the X. laevis homologue of the P2X7 receptor.
Altogether, xP2X7 shows a unique combination of properties,
known from human, mouse and rat P2X7.
A slowly increasing current component has earlier been
observed for rP2X7 in Xenopus oocytes but was not accom-
panied by pore formation [13]. It has been reported that the
large pore of P2X7 receptors can be selectively blocked by
HMA [21]. In Fig. 4A we demonstrate that the slowly increas-
ing conductance, mediated by xP2X7, could be completely
blocked by HMA (100 WM). This represents a strong hint
that xP2X7 might be su⁄cient to induce formation of large
pores in oocytes.
To analyze this property in more detail, we replaced Na in
the extracellular solution by NMDG. Under these condi-
tions, ATP (1 mM) produced a slowly increasing inward cur-
rent (Fig. 4B). Following washout of ATP, this inward cur-
rent deactivated fast but only partially, followed by a slower,
delayed deactivation process. To con¢rm formation of large
pores, we applied repetitive voltage ramps from 3120 mV to
+20 mV within 1 s every 10 s. As is shown in Fig. 4C, the
reversal potential signi¢cantly shifted to less negative values
during activation of xP2X7 receptors (from 359.0 þ 2.8 mV to
310.2 þ 3.6 mV within 5 min; n = 8; P6 0.001). This re£ects
an approximately seven-fold increase in relative permeability
of NMDG compared to Na from 0.15 þ 0.02 to 1.01 þ 0.14
(Fig. 4D; P6 0.001). As a control, the same protocol was
carried out with extracellular solution containing Na. Dur-
ing 5 min of ATP application the reversal potentials stayed
stable (310.2 þ 1.4 mV; n = 8; Fig. 4C, inset).
A further property of large pores, formed following activa-
tion of P2X7 receptors, is the permeabilization of the plasma
membrane for dye molecules such as the propidium dye YO-
PRO-1. Incubation of xP2X7 receptor expressing oocytes with
extracellular solution containing BzATP (300 WM) and YO-
PRO-1 (10 WM) for 5 min resulted in a £uorescence of whole
oocytes indicating YO-PRO-1 uptake (Fig. 4E, left ; n = 6; not
quanti¢ed). In contrast, non-injected oocytes, which had been
analyzed using this protocol, did not show any dye uptake
(Fig. 4E, right; n = 6).
Block of the slowly increasing current component by HMA,
increasing inward current caused by shift in reversal potential
during prolonged xP2X7 activation with NMDG as extracel-
lular cation, and YO-PRO-1 uptake clearly demonstrate pore
formation. Thus, besides the unique pharmacological pro¢le
of xP2X7, the most striking feature of this receptor is its
ability to induce pore formation when expressed in X. laevis
oocytes (consistent in oocytes from 14 di¡erent frogs). There-
fore, the xP2X7 receptor might prove a valuable tool to iden-
tify domains crucial for large pore formation.
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